| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 28.96B | 29.68B | 28.53B | 26.55B | 24.63B | 21.72B |
| Gross Profit | 7.23B | 7.22B | 6.82B | 5.68B | 5.02B | 4.68B |
| EBITDA | 2.91B | 2.88B | 2.64B | 1.94B | 1.55B | 1.44B |
| Net Income | -297.87M | 1.03B | -628.78M | 268.87M | 60.14M | -82.14M |
Balance Sheet | ||||||
| Total Assets | 29.67B | 32.72B | 28.51B | 28.46B | 26.47B | 25.21B |
| Cash, Cash Equivalents and Short-Term Investments | 5.00B | 5.64B | 4.62B | 5.23B | 3.85B | 3.18B |
| Total Debt | 14.84B | 15.73B | 13.96B | 13.02B | 12.85B | 11.19B |
| Total Liabilities | 21.24B | 22.55B | 20.41B | 20.17B | 19.25B | 18.29B |
| Stockholders Equity | 8.43B | 10.17B | 8.09B | 8.29B | 7.22B | 6.92B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | -794.97M | -1.59B | 1.57B | -869.02M | -795.41M |
| Operating Cash Flow | 0.00 | 2.28B | 509.02M | 2.05B | 279.37M | 945.12M |
| Investing Cash Flow | 0.00 | -3.22B | -1.30B | -667.43M | -1.60B | -1.56B |
| Financing Cash Flow | 0.00 | 1.56B | 912.72M | -445.05M | 1.45B | -169.44M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
77 Outperform | ¥28.44B | 11.37 | ― | 2.76% | 6.93% | 28.54% | |
76 Outperform | ¥22.26B | 14.08 | ― | 3.31% | 0.67% | 14.92% | |
67 Neutral | ¥12.82B | 15.19 | ― | 3.84% | 3.13% | -7.92% | |
66 Neutral | ¥8.17B | 6.08 | 3.72% | 1.17% | 4.02% | ― | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
63 Neutral | ¥6.64B | 9.00 | ― | 3.91% | 36.47% | 1851.64% | |
57 Neutral | ¥8.36B | 59.60 | ― | 5.64% | 1.31% | -347.76% |